As an infectious disease clinician-scientist and medical director of OHSU Occupational Health Services, Curlin has supported the health and wellbeing of OHSU health care workers during the COVID-19 pandemic.

He and his colleagues have enrolled more than 2,500 OHSU workers and patients in clinical studies to evaluate the effectiveness of COVID-19 vaccination, including the frequency of breakthrough infections and “super immunity” for those who are both vaccinated and have fallen ill to COVID-19. He also leads OHSU’s involvement in the AstraZeneca COVID-19 vaccine clinical trial.

Curlin has conducted HIV/AIDS vaccine research for more than 15 years, including at OHSU’s Vaccine & Gene Therapy Institute. Prior to joining OHSU in 2015, he was involved in HIV/AIDS research through the U.S. Centers for Disease Control and Prevention, the HIV Vaccine Trials Network, the Fred Hutchison Cancer Research Center and the University of Washington.

Curlin is also involved in scientific exchanges with Thai researchers through OHSU Global, which provides education, leads clinical initiatives and conducts research in partnership with institutions around the world.

Curlin is a board-certified infectious disease physician and a diplomate of the American Board of Internal Medicine.

Download a photo of Marcel Curlin, M.D.